C-myb activates CXCL12 transcription in T47D and MCF7 breast cancer cells

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 1, 2010, Pages 1-7

  Chen, Li ^a   Xu, Siguang ^a   Zeng, Xiaohua ^a,b   Li, Junjie ^a   Yin, Wenjin ^a   Chen, Ying ^a   Shao, Zhimin ^a   Jin, Wei ^a  

^a FUDAN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

C myb; CXCL12 promoter; Transcription regulation

Indexed keywords

MESSENGER RNA; PROTEIN C MYB; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; BREAST TUMOR; CHROMATIN IMMUNOPRECIPITATION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; REGULATORY SEQUENCE; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHEMOKINE CXCL12; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYB; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION;

EID: 73549088743     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp108     Document Type: Article

References (26)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1: 27-31.
2. Battegay EJ. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 1995, 73: 333-346.
3. Mü ller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME and McClanahan T, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410: 50-56.
4. Mashino K, Sadanaga N, Yamaguchi H, Tanaka F, Ohta M, Shibuta K and Inoue H, et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 2002, 62: 2937-2941.
5. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG and Batchelor TT. Angiogenesis in brain tumors. Nat Rev Neurosci 2007, 8: 610-622.
6. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R and Carey VJ, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121: 335-348.
7. Suzuki M, Mohamed S, Nakajima T, Kubo R, Tian L, Fujiwara T and Suzuki H, et al. Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis. Int J Oncol 2008, 33: 113-119.
8. Sowińska A and Jagodzinski PP. RNA interference-mediated knockdown of DNMT1 and DNMT3B induces CXCL12 expression in MCF-7 breast cancer and AsPC1 pancreatic carcinoma cell lines. Cancer Lett 2007, 255: 153-159.
9. Wendt MK, Cooper AN and Dwinell MB. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. Oncogene 2008, 27: 1461-1471.
10. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME and Capla JM, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10: 858-864.
11. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME and Capla JM, et al. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 2005, 15: 57-63.
12. García-Moruja C, Alonso-Lobo JM, Rueda P, Torres C, González N, Bermejo M and Luque F, et al. Functional characterization of SDF-1 proximal promoter. J Mol Biol 2005, 348: 43-62.
13. Klempnauer KH, Ramsay G, Bishop JM, Moscovici MG, Moscovici C, McGrath JP and Levinson AD. The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb. Cell 1983, 33: 345-355.
14. Plaza S, Turque N, Dozier C, Bailly M and Saule S. c-myb acts as transcriptional activator of the quail PAX6 (PAX-QNR) promoter through two different mechanisms. Oncogene 1995, 10: 329-340.
15. O'Rourke JP and Ness SA. Alternative RNA splicing produces multiple forms of c-myb with unique transcriptional activities. Mol Cell Biol 2008, 28: 2091-2101.
16. Lei W, Liu F and Ness SA. Positive and negative regulation of c-myb by cyclin D1, cyclin-dependent kinases, and p27Kip1. Blood 2005, 105: 3855-3861.
17. Tahirov TH, Sato K, Ichikawa-Iwata E, Sasaki M, Inoue-Bungo T, Shiina M and Kimura K, et al. Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter. Cell 2002, 108: 57-70.
18. Andersson KB, Kowenz-Leutz E, Brendeford EM, Tygsett AH, Leutz A and Gabrielsen OS. Phosphorylation-dependent down-regulation of c-myb DNA binding is abrogated by a point mutation in the v-myb oncogene. J Biol Chem 2003, 278: 3816-3824.
19. Kitagawa K, Kotake Y and Kitagawa M. Ubiquitin-mediated control of oncogene and tumor suppressor gene products. Cancer Sci 2009, 100: 1374-1381.
20. Introna M, Luchetti M, Castellano M, Arsura M and Golay J. The myb oncogene family of transcription factors: potent regulators of hematopoietic cell proliferation and differentiation. Semin Cancer Biol 1994, 5: 113-124.
21. Thompson MA and Ramsay RG. Myb: an old oncoprotein with new roles. BioEssays 1995, 17: 341-350.
22. Ramsay RG, Friend A, Vizantios Y, Freeman R, Sicurella C, Hammett F and Armes J, et al. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-myb. Cancer Res 2000, 60: 1805-1809.
23. McHale K, Tomaszewski JE, Puthiyaveettil R, Livolsi VA and Clevenger CV. Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma. Mod Pathol 2008, 21: 565-571.
24. Drabsch Y, Hugo H, Zhang R, Dowhan DH, Miao YR, Gewirtz AM and Barry SC, et al. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proc Natl Acad Sci USA 2007, 104: 13762-13767.
25. Fang F, Rycyzyn MA and Clevenger CV. Role of c-myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells. Endocrinology 2009, 150: 1597-1606.
26. Rønneberg JA, Tost J, Solvang HK, Alnaes GI, Johansen FE, Brendeford EM and Yakhini Z, et al. GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas. Cancer Res 2008, 68: 5562-5571.